Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Antibiotics. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112694430B reveals a safe palladium-catalyzed route using solid CO sources, offering significant cost reduction in API manufacturing and reliable supply chains.
Novel palladium-catalyzed reductive aminocarbonylation method for high-purity quinolinone derivatives, offering scalable routes for pharmaceutical intermediates.
Patent CN114478375A reveals a novel Pd-catalyzed route for quinolin-2(1H)one derivatives, offering cost-effective API intermediate manufacturing with high yields.
Discover a one-step Pd-catalyzed synthesis of 1,5-dihydro-2H-pyrrole-2-ketone with 70-92% yield. Eliminate multi-step processes and supply chain risks for API intermediates.
Discover how new asymmetric synthesis of (S,S)-2,8-diazabicyclononane reduces costs and steps for moxifloxacin production, ensuring supply chain stability.
Discover how Fmoc-protected amoxicillin synthesis reduces impurities by 30% and cuts production steps. Solve supply chain risks for API manufacturing with scalable CDMO solutions.
Solve high production costs and safety risks in tulathromycin synthesis. Our CDMO expertise delivers 76% yield with water-based, metal-free catalysis. Request a quote today.
Solve supply chain gaps for (2S)-2-amino-4-cyclopropylbutyric acid with novel Suzuki coupling. 99.4% purity, 91.6% yield, and no special equipment required for GMP production.
Solve supply chain risks with a novel palladium-catalyzed method for 3-arylquinoline-2(1H) ketone derivatives. 91-97% yields, broad functional group tolerance, and cost-efficient raw materials. Ideal for API synthesis.
Solve supply chain risks with this novel palladium-catalyzed route for 3-arylquinoline-2(1H) ketone derivatives. High yield, broad functional group tolerance, and cost-effective raw materials.
Solve chiral resolution challenges in moxifloxacin manufacturing with this patent-validated method. Achieve 80%+ yields, reduce costs, and ensure supply chain stability for your API production.
Discover a chiral resolution-free synthesis for moxifloxacin with high yield and purity. Reduce production costs and supply chain risks for your API manufacturing.
Solve high-cost challenges in iclaprim synthesis. New acetic acid method replaces expensive cerium reagents, cuts production costs by 70%, and ensures >98% purity for scalable API manufacturing.
Revolutionize BPTA production with microwave-assisted synthesis: 97%+ yield, 99%+ purity, and 30% cost reduction. Eliminate triphenylphosphine dependency for stable cephalosporin supply chains.
Eliminate high-pressure hydrogenation and resolution steps in Moxifloxacin side chain production. Achieve 99%+ ee and 20-30% yield with simplified process. Reduce costs and supply chain risks for API manufacturing.
Discover how copper-catalyzed interrupted Kinugasa reaction enables high-yield, enantioselective synthesis of polysubstituted beta-lactams for novel antibiotic development. Reduce supply chain risks.
Overcome thiamphenicol synthesis challenges with chiral catalysis: reduce waste, improve yield, and ensure GMP compliance. Find reliable suppliers for high-purity API.